Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119153662 | 11915366 | 2 | F | 2001 | 20160829 | 20160114 | 20160902 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-11527082 | BRISTOL MYERS SQUIBB | 0.00 | YR | F | Y | 1.00000 | KG | 20160902 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119153662 | 11915366 | 1 | PS | ZERIT | STAVUDINE | 1 | Transplacental | EXPOSURE BEGAN AT CONCEPTION. | U | 20412 | 60 | MG | CAPSULE, HARD | QD | |||||
| 119153662 | 11915366 | 2 | SS | VIDEX | DIDANOSINE | 1 | Transplacental | EXPOSURE BEGAN AT CONCEPTION. | U | 0 | 250 | MG | QD | ||||||
| 119153662 | 11915366 | 3 | SS | INVIRASE | SAQUINAVIR MESYLATE | 1 | Transplacental | EXPOSURE BEGAN AT CONCEPTION. | U | 0 | 400 | MG | QD | ||||||
| 119153662 | 11915366 | 4 | SS | NORVIR | RITONAVIR | 1 | Transplacental | EXPOSURE BEGAN AT CONCEPTION. | U | 0 | 600 | MG | QD | ||||||
| 119153662 | 11915366 | 5 | C | BACTRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Transplacental | EXPOSURE DURING GESTATION. | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119153662 | 11915366 | 1 | Product used for unknown indication |
| 119153662 | 11915366 | 2 | Product used for unknown indication |
| 119153662 | 11915366 | 3 | Product used for unknown indication |
| 119153662 | 11915366 | 4 | Product used for unknown indication |
| 119153662 | 11915366 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119153662 | 11915366 | CA |
| 119153662 | 11915366 | DE |
| 119153662 | 11915366 | LT |
| 119153662 | 11915366 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119153662 | 11915366 | Atrioventricular septal defect | |
| 119153662 | 11915366 | Death neonatal | |
| 119153662 | 11915366 | Foetal exposure during pregnancy | |
| 119153662 | 11915366 | Heart disease congenital | |
| 119153662 | 11915366 | Premature baby | |
| 119153662 | 11915366 | Trisomy 18 |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119153662 | 11915366 | 1 | 20010825 | 0 | ||
| 119153662 | 11915366 | 2 | 20010825 | 0 | ||
| 119153662 | 11915366 | 3 | 20010825 | 0 | ||
| 119153662 | 11915366 | 4 | 20010825 | 0 |